Healius will be in a “material net cash position’’ following the sale of its Lumus Imaging division for $965m, and will ...

The sale represents a total consideration of $965 million with cash proceeds estimated to be around $835 million. The sale of Lumus which accounts for almost half of the fiscal 2024 group operating ...

Healius is set to become debt-free after selling its radiology business, Lumus Imaging, for $965 million, exceeding analyst ...

Shares in the pathology company jumped 6 per cent after it achieved a robust price for Lumus, which does MRI, X-rays and CT ...

Healius Ltd. agreed to sell its Lumus imaging unit to a private equity group for A$965 million ($657 million), as the ...

Previously, Galmed reported results from the Open-Label part of its Phase 3 NASH study, which demonstrated that treatment with Aramchol 300mg BID resulted in a high rate of subjects with histological ...

GRM and HistoWiz expand their partnership, with HistoWiz now using GRM's pathology storage services for blocks and slides.

Katharine Mitropoulos, an author and the founder of Set Sail Press LLC, hosted a book launch event for her second book, ...

Healius has confirmed that it has sold its Lumus Imaging business to private equity firm Affinity Equity Partners, in a deal ...

The jury is currently out on whether pathology giant Healius will be better off without its Lumus imaging business.

Axlab, a Danish innovator within solutions for pathology laboratories, is expanding its presence in the US to meet the ...

While it’s a shame it got to the point that the company had to sell its radiology arm, and that it took so long to get there, ...